Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1996
Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease
C S Probert, A Chott, J R Turner, et al.
Gastroenterology
|
December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group
R N Fedorak, A Gangl, C O Elson, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1995
Intraperitoneal administration of tetanus toxoid elicits a specific response of antibody-secreting cells in the peritoneal cavity
C Lue, A W Van den Wall Blake, S J Prince, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1996
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance
C O Elson, K W Beagley, A T Sharmanov, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1995
Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine
K W Beagley, K Fujihashi, A S Lagoo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1997
Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora
S L Brandwein, R P McCabe, Y Cong, et al.
Mucosal Immunology
|
July 11, 2018
Expanded TCRβ CDR3 clonotypes distinguish Crohn's disease and ulcerative colitis patients
J Wu, A H Pendegraft, M Byrne-Steele, et al.
Gut
|
October 4, 2008
Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation
H Takedatsu, K D Taylor, L Mei, et al.
Alimentary Pharmacology & Therapeutics
|
February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease
B G Feagan, W J Sandborn, J P Baker, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1996
Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease
C S Probert, A Chott, J R Turner, et al.
Gastroenterology
|
December 13, 2000
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group
R N Fedorak, A Gangl, C O Elson, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1995
Intraperitoneal administration of tetanus toxoid elicits a specific response of antibody-secreting cells in the peritoneal cavity
C Lue, A W Van den Wall Blake, S J Prince, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1996
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance
C O Elson, K W Beagley, A T Sharmanov, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1995
Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine
K W Beagley, K Fujihashi, A S Lagoo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1997
Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora
S L Brandwein, R P McCabe, Y Cong, et al.
Mucosal Immunology
|
July 11, 2018
Expanded TCRβ CDR3 clonotypes distinguish Crohn's disease and ulcerative colitis patients
J Wu, A H Pendegraft, M Byrne-Steele, et al.
Gut
|
October 4, 2008
Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation
H Takedatsu, K D Taylor, L Mei, et al.
Alimentary Pharmacology & Therapeutics
|
February 16, 2005
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease
B G Feagan, W J Sandborn, J P Baker, et al.
Page
of 11